Dr. Chris L. Cary, MD

Dr. Cary practices at Beth Israel Deaconess Hospital-Milton in Milton, Massachusetts, part of Beth Israel Lahey Health.

Dr. Cary's NPI, 1326466525, was assigned on April 3, 2014. Dr. Cary holds Massachusetts license 270044.

Dr. Cary's primary practice is Beth Israel Deaconess Hospital-Milton, at 199 Reedsdale Road, Milton, MA 02186 in Norfolk County. The practice phone is (617) 696-4600.

Dr. Cary's primary practice is Beth Israel Deaconess Hospital-Milton in Milton, Massachusetts, part of Beth Israel Lahey Health. Dr. Cary is also affiliated with Lowell General Hospital. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Cary to 5 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cary practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Cary's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Cary is licensed in Massachusetts.

CMS data shows 764 Medicare services from Dr. Cary across 4 procedure codes in 2024, for 560 Medicare patients. Medicare paid $75,213 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 560 Medicare patients who saw Dr. Cary in 2024. The largest group is 75 to 84, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cary's median patient age at 63, with 61% women.

In 2024, Dr. Cary wrote 702 Medicare Part D claims for 387 patients. 94% of them were for generic drugs. CMS names the drug for 542 of them, across 14 drugs with 11 or more claims each, at $8,453 in total drug cost. In 2023, CMS named 183 claims across 8 drugs.

Dr. Cary accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Cary, published from 2014 to 2016. Dr. Cary's most frequent co-authors are George L. Hines, MD, Liudvikas J. Jagminas, MD and Peter B. Smulowitz, MD.

CMS Open Payments shows 54 general payments to Dr. Cary from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 60% of the total. Abbott Laboratories paid the most, $1,445.